Benzhydrylpiperazine compounds inhibit cholesterol-dependent cellular entry of hepatitis C Virus
Publication information:
Chamoun-Emanuelli A, Pecheur E, Chen Z. Benzhydrylpiperazine compounds inhibit cholesterol-dependent cellular entry of hepatitis C Virus.
Antiviral Res. 2014;109:141–8.